Navamedic ASA (OSL:NAVA)

Navamedic ASA Statistics

Total Valuation

Navamedic ASA has a market cap or net worth of NOK 379.75 million. The enterprise value is 451.35 million.

Market Cap	379.75M
Enterprise Value	451.35M

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Navamedic ASA has 17.66 million shares outstanding.

Current Share Class	17.66M
Shares Outstanding	17.66M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.37%
Owned by Institutions (%)	52.55%
Float	12.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	25.75
PS Ratio	0.70
PB Ratio	1.77
P/TBV Ratio	n/a
P/FCF Ratio	7.48
P/OCF Ratio	7.02
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.86, with an EV/FCF ratio of 8.88.

EV / Earnings	-41.23
EV / Sales	0.83
EV / EBITDA	8.86
EV / EBIT	12.52
EV / FCF	8.88

Financial Position

The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.52.

Current Ratio	1.34
Quick Ratio	0.69
Debt / Equity	0.52
Debt / EBITDA	2.20
Debt / FCF	2.20
Interest Coverage	2.43

Financial Efficiency

Return on equity (ROE) is -4.97% and return on invested capital (ROIC) is 6.42%.

Return on Equity (ROE)	-4.97%
Return on Assets (ROA)	4.41%
Return on Invested Capital (ROIC)	6.42%
Return on Capital Employed (ROCE)	11.13%
Revenue Per Employee	12.92M
Profits Per Employee	-260,619
Employee Count	42
Asset Turnover	1.06
Inventory Turnover	3.00

Taxes

In the past 12 months, Navamedic ASA has paid 8.74 million in taxes.

Income Tax	8.74M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.68% in the last 52 weeks. The beta is 0.37, so Navamedic ASA's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	-37.68%
50-Day Moving Average	21.28
200-Day Moving Average	24.74
Relative Strength Index (RSI)	47.96
Average Volume (20 Days)	5,040

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Navamedic ASA had revenue of NOK 542.59 million and -10.95 million in losses.

Revenue	542.59M
Gross Profit	212.48M
Operating Income	36.06M
Pretax Income	-2.21M
Net Income	-10.95M
EBITDA	47.83M
EBIT	36.06M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 40.31 million in cash and 111.91 million in debt, giving a net cash position of -71.60 million or -4.05 per share.

Cash & Cash Equivalents	40.31M
Total Debt	111.91M
Net Cash	-71.60M
Net Cash Per Share	-4.05
Equity (Book Value)	214.27M
Book Value Per Share	n/a
Working Capital	54.62M

Cash Flow

In the last 12 months, operating cash flow was 54.13 million and capital expenditures -3.33 million, giving a free cash flow of 50.80 million.

Operating Cash Flow	54.13M
Capital Expenditures	-3.33M
Free Cash Flow	50.80M
FCF Per Share	2.88

Margins

Gross margin is 39.16%, with operating and profit margins of 6.65% and -2.02%.

Gross Margin	39.16%
Operating Margin	6.65%
Pretax Margin	-0.41%
Profit Margin	-2.02%
EBITDA Margin	8.82%
EBIT Margin	6.65%
FCF Margin	9.36%

Dividends & Yields

Navamedic ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.88%
FCF Yield	13.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5